Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
Law banning copay coupons didn't boost generic drug use, study finds
Beckers Hospital Review
Mon, 06/21/21 - 10:21 pm
generics
copay coupons
California
FDA launches global Generic Drug Cluster
RAPS.org
Mon, 06/14/21 - 11:59 pm
FDA
generics
regulatory
Seven insurers sue CVS for allegedly inflating drug prices
MedCity News
Fri, 05/28/21 - 11:21 am
CVS Health
insurers
drug pricing
generics
FDA releases batch of 21 product-specific guidances
RAPS.org
Wed, 05/19/21 - 11:21 pm
FDA
regulatory
generics
Novartis' Sandoz embarks on €150M antibiotics manufacturing upgrade in Europe
Fierce Pharma
Tue, 05/18/21 - 11:01 am
Novartis
Sandoz
generics
Europe
drug manufacturing
Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free rein
Fierce Pharma
Mon, 05/17/21 - 10:59 pm
Novartis
Sandoz
generics
Supreme Court
Amgen
Embrel
biosimilar
Vaccine waiver talks can make drug firms the heroes, U.S. trade chief says
Reuters
Fri, 05/14/21 - 12:01 am
vaccines
COVID-19
intellectual property
generics
FDA welcomes alternative approaches to generic drug development
RAPS.org
Wed, 05/5/21 - 09:57 pm
generics
FDA
CDER
drug development
FDA issues 36 new and revised product-specific guidances
RAPS.org
Thu, 03/25/21 - 10:49 pm
FDA
generics
bioequivalence
Alembic pulls blood pressure generic after complaint reveals labeling mix-up
Fierce Pharma
Thu, 03/25/21 - 11:50 am
generics
Alembic Pharmaceuticals
telmisartan
product recalls
Teva sees room for growth with FDA communications and complex generics, COO says
Endpoints
Wed, 03/24/21 - 11:13 pm
Teva Pharmaceutical
generics
FDA
Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity
Endpoints
Tue, 03/9/21 - 10:49 am
Novartis
generics
Sandoz
FDA
Aubagio
multiple sclerosis
MS
Generics companies face risk as SCOTUS questions patent tribunal’s constitutionality
MedCity News
Fri, 03/5/21 - 10:24 am
generics
Supreme Court
patents
biosimilars
devices
AstraZeneca breathes sigh of relief as court blocks US Symbicort generic
Pharmaforum
Wed, 03/3/21 - 10:17 am
AstraZeneca
Symbicort
generics
patents
Perrigo to sell generic drugs business for $1.55 billion
Reuters
Tue, 03/2/21 - 12:07 am
Perrigo
generics
M&A
Novartis' Sandoz doubles down on antibiotics with $500M deal for GSK brands
Fierce Pharma
Thu, 02/11/21 - 10:26 pm
Novartis
Sandoz
generics
antibiotics
GSK, Teva on-again, off-again lawsuit is back on: Will 'skinny labeling' get a reprieve?
Fierce Pharma
Thu, 02/11/21 - 10:47 am
GSK
generics
skinny labels
labeling
Teva Pharmaceutical
Bristol Myers Squibb can grow through Revlimid generics, execs insist, pointing to key launches
Fierce Pharma
Thu, 02/4/21 - 08:15 pm
Bristol-Myers Squibb
generics
Revlimid
Zeposia
Reblozyl
Onureg
Teva, Mylan and fellow valsartan makers have to face consumer fraud claims: judge
Fierce Pharma
Mon, 02/1/21 - 11:07 pm
Teva Pharmaceutical
Mylan
Valsartan
generics
NDMA
Civica Rx lays out $124M sterile injectables plant, pegged to supply COVID-19 drugs and more
Fierce Pharma
Mon, 01/25/21 - 11:07 am
Civica Rx
drug manufacturing
generics
Phlow
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »